Proteomics companies create new network

A group of 13 proteomics service companies and providers have banded together to create the Proteomics Innovation Network. Its stated mission is to generate "from sample to discovery" solutions in all facets of proteomics, including expression, identification, characterization, interaction and function. Release

Suggested Articles

Janssen’s BCMA-targeting CAR-T therapy eliminated tumors in 69% of patients with advanced multiple myeloma in a small phase 1 study.

In a study, BMS' CAR-T therapy banished tumors in more than half and shrank tumors in nearly three-quarters of relapsed blood cancer patients.

Novartis unveiled more data showing how its asthma combo QMF149 fared against the standard of care: a combination of the same types of drugs.